Zobrazeno 1 - 10
of 102
pro vyhledávání: '"Meng Chung"'
Autor:
Ibrahim Haruna Shanono, Aisha Muhammad, Nor Rul Hasma Abdullah, Hamdan Daniyal, Meng Chung Tiong
Publikováno v:
Journal of Electrical Systems and Information Technology, Vol 8, Iss 1, Pp 1-23 (2021)
Abstract Optimal reactive power dispatch (ORPD) plays a significant role in the control and smooth operation of the power system through the enhancement of the network’s reliability, security, and economic aspects. This paper presents a bibliometri
Externí odkaz:
https://doaj.org/article/9bb796d2b9c04211afa1d89c6415e6e7
Publikováno v:
Applications of Modelling and Simulation, Vol 3, Iss 2, Pp 111-118 (2019)
This paper presents the application of controller hardware-in-the-loop (C-HIL) for real-time study of maximum power point tracking (MPPT) algorithm in solar photovoltaic (PV) system. The testing platform in this study which consist of three series co
Externí odkaz:
https://doaj.org/article/5b6a75b64c544850b9e6ec7184f3077c
Autor:
Damian, Sophea Elmmydya, Wong, Ling Ai, Shareef, Hussain, Chan, C.K., Moh, T.S.Y., Tiong, Meng Chung
Publikováno v:
In Journal of Power Sources 1 February 2025 628
Publikováno v:
Journal of Medical Case Reports, Vol 6, Iss 1, p 316 (2012)
Abstract Introduction A number of vision defects have been reported in association with albinism, such as photophobia, nystagmus and astigmatism. In many cases only prescription sunglasses are prescribed. In this report, the effectiveness of low-visi
Externí odkaz:
https://doaj.org/article/034f62ff2a1c4eb7a1bbd7f8a29c52e8
Autor:
Meng, Chung Kin, Piaralal, Shishi Kumar, Islam, Md Aminul, Yusof, Mohd Faizal Bin, Chowdhury, Rubaiyat Shaimom
Publikováno v:
In Heliyon September 2023 9(9)
Autor:
Damian, Sophea Elmmydya, Wong, Ling Ai, Shareef, Hussain, Ramachandaramurthy, Vigna K., Chan, C.K., Moh, T.S.Y., Tiong, Meng Chung
Publikováno v:
In Journal of Energy Storage 10 December 2022 56 Part B
Autor:
Be-Sheng Kuo, Chao-Hung Li, Jiun-Bo Chen, Yu-Yu Shiung, Chia-Yu Chu, Chih-Hung Lee, Yaw-Jen Liu, Je-Hung Kuo, Cindy Hsu, Hsiao-Wen Su, Ywan-Feng Li, Annie Lai, Yueh-Feng Ho, Yi-Ning Cheng, Hong-Xuan Huang, Meng-Chung Lung, Ming-Syue Wu, Fu-Hung Yang, Chen-Han Lin, William Tseng, Jasper Yang, Chia-Yin Lin, Pei-Hua Tsai, Heng-Kwei Chang, Yi-Jen Wang, Techeng Chen, Shugene Lynn, Mei-June Liao, Chang Yi Wang
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 15 (2023)
Over the last 2 decades, omalizumab is the only anti-IgE antibody that has been approved for asthma and chronic spontaneous urticaria (CSU). Ligelizumab, a higher-affinity anti-IgE mAb and the only rival viable candidate in late-stage clinical trials
Externí odkaz:
https://doaj.org/article/fac742fb52aa43f781d834d2b06813e8
Publikováno v:
IJIREEICE. 11
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3653335d08941baeb9a01b6b3314ce3
https://doi.org/10.17148/ijireeice.2023.11101
https://doi.org/10.17148/ijireeice.2023.11101
Autor:
Be-Sheng Kuo, Chao-Hung Li, Jiun-Bo Chen, Yu-Yu Shiung, Chia-Yu Chu, Chih-Hung Lee, Yaw-Jen Liu, Je-Hung Kuo, Cindy Hsu, Hsiao-Wen Su, Ywan-Feng Li, Annie Lai, Yueh-Feng Ho, Yi-Ning Cheng, Hong-Xuan Huang, Meng-Chung Lung, Ming-Syue Wu, Fu-Hong Yang, Chen-Han Lin, William Tseng, Jasper Yang, Chia-Yin Lin, Pei-Hua Tsai, Heng-Kwei Chang, Yi-Jen Wang, Techeng Chen, Shugene Lynn, Mei-June Liao, Chang Yi Wang
Publikováno v:
Journal of Clinical Investigation. 132
Over the last 2 decades, omalizumab is the only anti-IgE antibody that has been approved for asthma and chronic spontaneous urticaria (CSU). Ligelizumab, a higher-affinity anti-IgE mAb and the only rival viable candidate in late-stage clinical trials
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecdf7e344f33a55e4f94606af4a3de45
https://doi.org/10.1172/jci157765
https://doi.org/10.1172/jci157765
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.